Benzinga | Jan 31, 2022 07:59AM EST

Raymond James Upgrades Arcturus Therapeutics to Market Perform

Raymond James analyst Steven Seedhouse upgrades Arcturus Therapeutics (NASDAQ:ARCT) from Underperform to Market Perform.